Pharmaceutical Guidelines/Updates

A blog about pharmaceutical Quality Assurance, Quality Control, Production and Regulatory Updates Provided by Regulatory Agencies.

Pages

Home
Regulatory Agencies
Guidelines
Disclaimer
Privacy Policy
Terms and conditions
Contact Us

Contact Us

Email This BlogThis!Share to X Share to Facebook Share to Pinterest

Subscribe to: Posts (Atom)

Search This Blog

Email Subscription

Enter your email address:

Delivered by FeedBurner

Popular Posts

Different Types of Training in Pharmaceutical Industries

Training plays an important role in any industry and it gives a clear understanding about the roles and responsibilities of a person worki...
Data Governance and Data Integrity (DI)

Introduction: Data governance and data integrity (DI) are important elements in ensuring the reliability of data and information obtained ...
Weighing balance calibration in Pharmaceutical

Preparations before calibration Before you can start the calibration of the weighing instrument, you should clarify a few things and ...
Information Requests and Discipline Review Letters of US FDA

· The Generic Drug User Fee Amendments of 2017 (GDUFA II) was signed into law on August 18, 2017 in order to facilitate timely acce...
Indian companies working on Covid-19 vaccines

Six Indian companies are working on a vaccine for COVID-19, joining global efforts to find a quick preventive for the deadly infection spre...
Guidance for changes to approved NDA or ANDA

FDA has published guidance to provide recommendations to holders of new drug applications (NDAs) and abbreviated new drug applications (A...

Blog Archive

▼ 2021 (1)
- ▼ February (1)
  - Data Governance and Data Integrity (DI)

► 2020 (15)
- ► December (1)
- ► November (2)
- ► July (1)
- ► June (4)
- ► May (7)

► 2017 (6)
- ► August (6)

Powered by Blogger.